Similar articles for PMID: 29584920

Year	Number of Results
1990	1
2006	3
2007	1
2008	1
2011	3
2012	10
2013	20
2014	16
2015	18
2016	26
2017	20
2018	40
2019	35
2020	41
2021	38
2022	31
2023	6
2024	0

1

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer.

Hillman RT, Chisholm GB, Lu KH, Futreal PA. Hillman RT, et al. J Natl Cancer Inst. 2018 Mar 1;110(3):265-72. doi: 10.1093/jnci/djx176. J Natl Cancer Inst. 2018. PMID: 29584920 Free PMC article.

2

Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study.

Bagnoli M, Canevari S, Califano D, Losito S, Maio MD, Raspagliesi F, Carcangiu ML, Toffoli G, Cecchin E, Sorio R, Canzonieri V, Russo D, Scognamiglio G, Chiappetta G, Baldassarre G, Lorusso D, Scambia G, Zannoni GF, Savarese A, Carosi M, Scollo P, Breda E, Murgia V, Perrone F, Pignata S, De Cecco L, Mezzanzanica D; Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Bagnoli M, et al. Lancet Oncol. 2016 Aug;17(8):1137-1146. doi: 10.1016/S1470-2045(16)30108-5. Epub 2016 Jul 9. Lancet Oncol. 2016. PMID: 27402147 Free article.

3

A Novel Scoring System for Pivotal Autophagy-Related Genes Predicts Outcomes after Chemotherapy in Advanced Ovarian Cancer Patients.

Niu Y, Sun W, Chen K, Fu Z, Chen Y, Zhu J, Chen H, Shi Y, Zhang H, Wang L, Shen HM, Xia D, Wu Y. Niu Y, et al. Cancer Epidemiol Biomarkers Prev. 2019 Dec;28(12):2106-2114. doi: 10.1158/1055-9965.EPI-19-0359. Epub 2019 Sep 18. Cancer Epidemiol Biomarkers Prev. 2019. PMID: 31533939

4

HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.

Miller KR, Patel JN, Zhang Q, Norris EJ, Symanowski J, Michener C, Sehouli J, Braicu I, Destephanis DD, Sutker AP, Jones W, Livasy CA, Biscotti C, Ganapathi RN, Tait DL, Ganapathi MK. Miller KR, et al. Gynecol Oncol. 2018 Apr;149(1):155-162. doi: 10.1016/j.ygyno.2018.01.022. Gynecol Oncol. 2018. PMID: 29402501

5

Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.

Xu L, Wu Y, Che X, Zhao J, Wang F, Wang P, Qu X, Liu Y, Li Z. Xu L, et al. DNA Cell Biol. 2019 Dec;38(12):1519-1528. doi: 10.1089/dna.2019.4826. Epub 2019 Oct 29. DNA Cell Biol. 2019. PMID: 31657627

6

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study.

Dugo M, Devecchi A, De Cecco L, Cecchin E, Mezzanzanica D, Sensi M, Bagnoli M. Dugo M, et al. Genes (Basel). 2019 Sep 5;10(9):678. doi: 10.3390/genes10090678. Genes (Basel). 2019. PMID: 31491988 Free PMC article.

7

Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.

Wang S, Yin C, Zhang Y, Zhang L, Tao L, Liang W, Pang L, Fu R, Ding Y, Li F, Jia W. Wang S, et al. Biomed Res Int. 2019 Jun 13;2019:2867372. doi: 10.1155/2019/2867372. eCollection 2019. Biomed Res Int. 2019. PMID: 31312656 Free PMC article.

8

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.

He J, Liu Y, Zhang L, Zhang H. He J, et al. Med Sci Monit. 2018 Dec 10;24:8933-8940. doi: 10.12659/MSM.911518. Med Sci Monit. 2018. PMID: 30531684 Free PMC article.

9

Immune profiling reveals prognostic genes in high-grade serous ovarian cancer.

Wu Y, Xia L, Zhao P, Deng Y, Guo Q, Zhu J, Chen X, Ju X, Wu X. Wu Y, et al. Aging (Albany NY). 2020 Jun 16;12(12):11398-11415. doi: 10.18632/aging.103199. Epub 2020 Jun 16. Aging (Albany NY). 2020. PMID: 32544083 Free PMC article.

10

Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.

Shilpi A, Kandpal M, Ji Y, Seagle BL, Shahabi S, Davuluri RV. Shilpi A, et al. JCO Clin Cancer Inform. 2019 Apr;3:1-9. doi: 10.1200/CCI.18.00096. JCO Clin Cancer Inform. 2019. PMID: 31002564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

271 results

Results by year